Preventable coronary heart disease events from control of cardiovascular risk factors in US adults with diabetes (projections from utilizing the UKPDS risk engine)

American Journal of Cardiology

Volumn 113, Issue 8, 2014, Pages 1356-1361

  Wong, Nathan D ^a   Patao, Christopher ^a   Malik, Shaista ^a   Iloeje, Uchenna ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Global Health Economics and Outcomes Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RISK REDUCTION; SEX DIFFERENCE; SMOKING; SYSTOLIC BLOOD PRESSURE; UNITED STATES;

ADULT; CORONARY DISEASE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NUTRITION SURVEYS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SURVIVAL RATE; UNITED STATES;

EID: 84897380878     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2013.12.042     Document Type: Article

References (20)

1. W.B. Kannel, and D.L. McGee Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham study Diabetes Care 2 1979 120 126
2. S. Malik, N.D. Wong, S.S. Franklin, T.V. Kamath, G.J. L'Italien, J.R. Pio, and R. Williams Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States Adults Circulation 110 2004 1239 1244
3. American Diabetes Association Economic costs of diabetes in the US in 2007 Diabetes Care 31 2008 596
4. K. Wong, D. Glovaci, S. Malik, S.S. Franklin, G. Wygant, U. Iloeje, H. Kan, and N.D. Wong Comparison of demographic factors and cardiovascular risk factor control among US adults with type 2 diabetes by insulin treatment classification J Diabetes Complications 26 2012 169 174
5. P. Gaede, H. Lund-Anderson, H.H. Parving, and O. Pedersen Effect of a multiple intervention on mortality in type 2 diabetes N Engl J Med 358 2008 580 591
6. The Action to Control Cardiovascular Risk in Diabetes Study Group Effects of intensive glucose lowering in type 2 diabetes N Engl J Med 358 2008 2545 2559
7. ADVANCE Collaborative Group A. Patel, S. MacMahon, J. Chalmers, B. Neal, L. Billot, M. Woodward, M. Marre, M. Cooper, P. Glasziou, D. Grobbee, P. Hamet, S. Harrap, S. Heller, L. Liu, G. Mancia, C.E. Mogensen, C. Pan, N. Poulter, A. Rodgers, B. Williams, S. Bompoint, B.E. de Galan, R. Joshi, and F. Travert Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes N Engl J Med 358 2008 2560 2572
8. The ACCORD Study Group Effects of intensive blood-pressure control in type 2 diabetes mellitus N Engl J Med 362 2010 1575 1585
9. R.J. Stevens, V. Kothari, A.I. Alder, I.M. Stratton, and United Kingdom Prospective Diabetes Study (UKPDS) Group The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56) Clin Sci 101 2001 671 679
10. N.D. Wong, D. Glovaci, K. Wong, S. Malik, S.S. Franklin, G. Wygant, and U. Iloeje Global cardiovascular disease risk assessment in United States adults with diabetes Diab Vas Dis Res 9 2012 146 152
11. rd, V.A. Diaz, and M.E. Geesey Changes in age at diagnosis of type 2 diabetes mellitus in the United States, 1988 to 2000 Ann Fam Med 3 2005 60 63
12. NHANES Laboratory Procedures Manual 2007-2008 US Department of Health and Human Services, Centers for Disease Control and Prevention Hyattsville, MD
13. American Diabetes Association Standards of Medical Care in diabetes 2007 Diabetes Care 30 suppl 1 2007 S4 S41
14. S.M. Grundy, J.I. Cleeman, S.R. Daniels, K.A. Donato, R.H. Eckel, B.A. Franklin, D.J. Gordon, R.M. Krauss, P.J. Savage, S.C. Smith Jr., J.A. Spertus, F. Costa American Heart Association National Heart, Lung, and Blood Institute Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart Lung and Blood Institute Scientific Statement Circulation 112 2005 2735 2752
15. A.P. Kong, X. Yang, G.T. Go, W.Y. So, W.B. Chan, R.C. Ma, V.W. Ng, C.C. Chow, C.S. Cockram, P.C. Tong, V. Wong, and J.C. Chan Effects of treatment targets on subsequent cardiovascular events in Chinese patients with type 2 diabetes Diabetes Care 30 2007 953 959
16. N.D. Wong, C. Patao, K. Wong, S. Malik, S.S. Franklin, and U. Iloeje Trends in control of cardiovascular risk factors among US adults with type 2 diabetes from 1999-2010: comparison by prevalent cardiovascular disease status Diab Vasc Dis Res 10 2013 505 513
17. NCEP Expert Panel Executive Summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of high blood cholesterol in adults (Adult Treatment Panel III) JAMA 285 2001 2486 2497
18. P. Greenland, J. Alpert, G.A. Beller, E.J. Benjamin, M.J. Budoff, Z.A. Fayad, E. Foster, M.A. Hlatky, J.M. Hodgson, F.G. Kushner, M.S. Lauer, L.J. Shaw, S.C. Smith Jr., A.J. Taylor, W.S. Weintraub, N.K. Wenger, A.K. Jacobs, S.C. Smith Jr., J.L. Anderson, N. Albert, C.E. Buller, M.A. Creager, S.M. Ettinger, R.A. Guyton, J.L. Halperin, J.S. Hochman, F.G. Kushner, R. Nishimura, E.M. Ohman, R.L. Page, W.G. Stevenson, L.G. Tarkington, C.W. Yancy American College of Cardiology Foundation American Heart Association 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults JACC 56 2010 2182 2199
19. K. Hoang, H. Ghandehari, V.A. Lopez, M.G. Barboza, and N.D. Wong Global coronary heart disease risk assessment of individuals with the metabolic syndrome in the U.S Diabetes Care 31 2008 1405 1409
20. N.D. Wong, J.R. Pio, S.S. Franklin, F.J. L'Italien, T.V. Kamath, and G.R. Williams Preventing coronary events by optimal control of blood pressure and lipids in patients with the metabolic syndrome Am J Cardiol 91 2003 1421 1426